281 related articles for article (PubMed ID: 17649809)
1. Expression of the carbohydrate tumour marker SLeX, SLeA (CA19-9), LeY and Thomsen-Friedenreich (TF) antigen on normal squamous epithelial tissue of the penis and vagina.
Wiest I; Schulze S; Kuhn C; Seliger C; Hausmann R; Betz P; Mayr D; Friese K; Jeschke U
Anticancer Res; 2007; 27(4A):1981-8. PubMed ID: 17649809
[TBL] [Abstract][Full Text] [Related]
2. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
3. Expression of the tumor markers sialyl Lewis A, sialyl Lewis X, Lewis Y, Thomsen-Friedenreich antigen, galectin-1 and galectin-3 in human osteoblasts in vitro.
Tübel J; Saldamli B; Wiest I; Jeschke U; Burgkart R
Anticancer Res; 2012 May; 32(5):2159-64. PubMed ID: 22593503
[TBL] [Abstract][Full Text] [Related]
4. Expression of the carbohydrate tumour marker Sialyl Lewis A, Sialyl Lewis X, Lewis Y and Thomsen-Friedenreich antigen in normal squamous epithelium of the uterine cervix, cervical dysplasia and cervical cancer.
Engelstaedter V; Fluegel B; Kunze S; Mayr D; Friese K; Jeschke U; Bergauer F
Histol Histopathol; 2012 Apr; 27(4):507-14. PubMed ID: 22374728
[TBL] [Abstract][Full Text] [Related]
5. Expression of the carbohydrate tumor marker Sialyl Lewis a (Ca19-9) in squamous cell carcinoma of the larynx.
Wiest I; Alexiou C; Mayr D; Schulze S; Kuhn C; Kunze S; Büttner M; Betz P; Jeschke U
Anticancer Res; 2010 May; 30(5):1849-53. PubMed ID: 20592391
[TBL] [Abstract][Full Text] [Related]
6. Expression of different carbohydrate tumour markers and galectins 1 and 3 in normal squamous and malignant epithelia of the upper aaerodigestive tract.
Wiest I; Alexiou C; Kuhn C; Schulze S; Kunze S; Mayr D; Betz P; Jeschke U; Dian D
Anticancer Res; 2012 May; 32(5):2023-9. PubMed ID: 22593483
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of sialyl Lewis antigen expression in the spread of gastric cancer. Flow cytometric DNA analysis.
Ashizawa T; Aoki T; Yamazaki T; Katayanagi S; Shimizu H; Koyanagi Y
J Exp Clin Cancer Res; 2003 Mar; 22(1):91-8. PubMed ID: 12725328
[TBL] [Abstract][Full Text] [Related]
8. Association between sialyl Lewis(a) expression and tumor progression in melanoma.
Kageshita T; Hirai S; Kimura T; Hanai N; Ohta S; Ono T
Cancer Res; 1995 Apr; 55(8):1748-51. PubMed ID: 7712483
[TBL] [Abstract][Full Text] [Related]
9. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
[TBL] [Abstract][Full Text] [Related]
10. Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage.
Ma Z; Yang H; Kessler M; Sperandio M; Mahner S; Jeschke U; von Schönfeldt V
Front Immunol; 2022; 13():919193. PubMed ID: 35837404
[TBL] [Abstract][Full Text] [Related]
11. Expression of inhibin/activin subunits, sialyl-lewis A (CA 19-9, sLea) and sialyl-Lewis X (sLex) carbohydrate antigens in a hydatidiform mole with persistent polymorphic trophoblastic hyperplasia.
Mylonas I; Makovitzky J; Vogel M; Shabani N; Jeschke U; Friese K
Anticancer Res; 2005; 25(3A):1725-30. PubMed ID: 16033091
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of UDP-galactose transporter messenger RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants.
Kumamoto K; Goto Y; Sekikawa K; Takenoshita S; Ishida N; Kawakita M; Kannagi R
Cancer Res; 2001 Jun; 61(11):4620-7. PubMed ID: 11389099
[TBL] [Abstract][Full Text] [Related]
13. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
Ravindranath NM; Nishimoto K; Chu K; Shuler C
Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta.
Richter DU; Jeschke U; Makovitzky J; Goletz S; Karsten U; Briese V; Friese K
Anticancer Res; 2000; 20(6D):5129-33. PubMed ID: 11326683
[TBL] [Abstract][Full Text] [Related]
15. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
Mylonas I; Mayr D; Walzel H; Shabani N; Dian D; Kuhn C; Kunze S; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):1975-80. PubMed ID: 17649808
[TBL] [Abstract][Full Text] [Related]
16. Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas.
Flucke U; Zirbes TK; Schröder W; Mönig SP; Koch V; Schmitz K; Thiele J; Dienes HP; Hölscher AH; Baldus SE
Anticancer Res; 2001; 21(3C):2189-93. PubMed ID: 11501845
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro.
Jeschke U; Richter DU; Hammer A; Briese V; Friese K; Karsten U
Histochem Cell Biol; 2002 Mar; 117(3):219-26. PubMed ID: 11914919
[TBL] [Abstract][Full Text] [Related]
18. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
19. Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.
Kolben T; Müller L; Meister S; Keilmann L; Buschmann C; Trillsch F; Burges A; Czogalla B; Mitter S; Schmoeckel E; Corradini S; Mahner S; Jeschke U; Kessler M; Beyer S
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3323-3335. PubMed ID: 35729354
[TBL] [Abstract][Full Text] [Related]
20. Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
Tang H; Singh S; Partyka K; Kletter D; Hsueh P; Yadav J; Ensink E; Bern M; Hostetter G; Hartman D; Huang Y; Brand RE; Haab BB
Mol Cell Proteomics; 2015 May; 14(5):1323-33. PubMed ID: 25733690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
